This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Real Estate Stocks: Equity Residential (EQR), Lineage, Inc. (LINE)

Tipranks - Sat May 23, 6:36AM CDT

There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Equity Residential (EQR) and Lineage, Inc. (LINE) with bullish sentiments.

Meet Samuel – Your Personal Investing Prophet

Equity Residential (EQR)

Piper Sandler analyst Alexander Goldfarb maintained a Buy rating on Equity Residential today and set a price target of $78.00. The company’s shares closed last Thursday at $65.76.

According to TipRanks.com, Goldfarb is a 3-star analyst with an average return of 1.7% and a 48.1% success rate. Goldfarb covers the NA sector, focusing on stocks such as Innovative Industrial Properties, Hudson Pacific Properties, and Curbline Properties Corp. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Equity Residential with a $71.16 average price target, an 8.2% upside from current levels. In a report issued on May 14, UBS also maintained a Buy rating on the stock with a $73.00 price target.

See today’s best-performing stocks on TipRanks >>

Lineage, Inc. (LINE)

RBC Capital analyst Michael Carroll maintained a Buy rating on Lineage, Inc. today and set a price target of $44.00. The company’s shares closed last Thursday at $40.05.

According to TipRanks.com, Carroll is a 5-star analyst with an average return of 7.9% and a 61.9% success rate. Carroll covers the NA sector, focusing on stocks such as Easterly Government Properties, American Healthcare REIT, Inc., and Diversified Healthcare Trust. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Lineage, Inc. with a $41.67 average price target, a 5.8% upside from current levels. In a report issued on May 9, TipRanks – DeepSeek also upgraded the stock to Buy with a $44.00 price target.

Read More on EQR:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.